ArticleDiabetology & metabolic syndrome2026
Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning.
Tanawan Kongmalai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.